A Comparative Study of Clinical Features and Survival Outcomes in Intrahepatic Cholangiocarcinoma Patients With and Without HBV Infection Undergoing Liver Resection

View at publisher Summarise with VIRAT
Authors: Hao Wang, Xingwu Zhu, Xiaoliang Yang, Jianbing Xuan, Maixuan Qiu, Liang Huang, Kui Wang, Jing Li
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUNDS: Previous studies have established an association between hepatitis B virus (HBV) infection and an elevated risk of intrahepatic cholangiocarcinoma (ICC); the prognostic implications of HBV infection in patients with ICC remain inadequately characterized. METHODS: Between January 2003 and December 2013, consecutive patients with histologically confirmed ICC who underwent curative-intent liver resection were retrospectively enrolled. Patients were stratified into two cohorts based on HBV status: HBV-positive (defined as HBsAg and/or HBV DNA positivity) and HBV-negative (both HBsAg and HBV DNA negative). Clinical characteristics and survival outcomes were systematically compared between the groups. RESULTS: A total of 1842 patients were included in the analysis, comprising 839 (45.5%) in the HBV-positive group and 1003 (54.5%) in the HBV-negative group. Compared with HBV-negative patients, those with HBV infection were more likely to be male (76.4% vs. 58.4%), had a higher prevalence of underlying liver cirrhosis (39.4% vs. 6.0%) and macrovascular invasion (12.6% vs. 8.2%), and exhibited lower rates of lymph node metastasis (3.7% vs. 12.0%) and perineural invasion (1.9% vs. 7.1%). The HBV-positive group demonstrated superior median overall survival (41 months vs. 27 months) and significantly higher overall survival rates at 1, 3, and 5 years. However, no significant difference in disease-free survival was observed between the two groups. CONCLUSION: HBV-associated ICC exhibited distinct tumor biology more similar to hepatocellular carcinoma, and patients with HBV-associated ICC exhibited improved overall survival compared to their HBV-negative counterparts.

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Pediatric Hepatobiliary Diseases and Treatments Hepatocellular Carcinoma Treatment and Prognosis

Publication details

Journal / source
ANZ Journal of Surgery
Volume
96
Issue
6
Pages
1634–1641
Publication date
26 March 2026
Language
EN